Japan: A recent study published in Experimental Dermatology has shed light on the impact of 1-year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitis (AD). The researchers showed that Dupilumab improved work productivity in Japanese patients with atopic dermatitis. They stated that long-term remission of pruritus and improved quality of life […]
A recent study published in the Influenza Other Respiratory Viruses journal examined the effectiveness of COVID-19 vaccines across various psychiatric disorders yielded promising outcomes. This study by Matthew Levy and team from the VISION Network in four US determined if mental health conditions influence the efficacy of mRNA COVID-19 vaccines. The study encompassed data from a […]
Japan: Findings from phase 2/3 TREASURE randomized clinical trial (RCT) that bone marrow-derived allogeneic stem cell therapy shortly after ischemic stroke was safe but failed to improve short-term outcomes. The findings were published online in JAMA Neurology on January 16, 2024. In the RCT with 206 participants, intravenous (IV) administration of intravenous allogeneic multipotent adult […]
In a recent study, the SavvyWire, a 0.035-inch pre-shaped guidewire with unique pacing properties and a distal pressure sensor, has demonstrated remarkable efficacy and safety during transcatheter aortic valve replacement (TAVR) procedures. The study, conducted across eight European centers, aimed to assess the device’s performance and safety in patients with severe aortic stenosis undergoing TAVR. […]
Australian researchers have discovered that a new potassium channel blocker nasal spray at bedtime has the potential to reduce the severity of sleep apnea in people and lower their blood pressure. The new research published in The Journal of Heart and Circulatory Physiology offers hope to millions of people around the world affected by sleep […]
Rezafungin and caspofungin effective treatment options for invasive candidiasis suggest a new study published in the Lancet Infectious Diseases. Rezafungin, a new US Food and Drug Administration-approved, long-acting echinocandin to treat candidaemia and invasive candidiasis, was efficacious with a similar safety profile to caspofungin in clinical trials. We conducted pooled analyses of the phase 2 […]
Germany: A recent study published in Diabetologia has shed light on survodutide dose-response effects on body weight and HbA1c reduction, compared with placebo and open-label semaglutide in patients with type 2 diabetes (T2D). Findings from the phase II randomized clinical trial showed a greater reduction in body weight and HbA1c levels after 16 weeks of […]
Short-term very low calorie diets are safe for teenagers living with moderate to severe obesity when closely monitored by an experienced dietitian, new research to be presented at the European Congress on Obesity (ECO 2024), has found. In addition, many of the adolescents who took part in the Australian study found a very low calorie […]
USA: A recent study published in Heart Rhythm has shown intravenous (IV) sotalol loading to be feasible and safe for atrial arrhythmias, and yield shorter hospitalization with low rates of adverse events. Antiarrhythmic drug therapy plays an important role in achieving rhythm control in atrial arrhythmias. In these patients, class III antiarrhythmic drugs are indicated […]
A new review of available evidence led by researchers at the Harvard Pilgrim Health Care Institute suggests that female reproductive characteristics may be overlooked as risk factors that contribute to later metabolic dysfunction. The review, “Reproductive risk factors across the female lifecourse and later metabolic health,” was published in the January 26 edition of Cell […]